Re:2,000% price hike for infant seizure drug called 'absurd'
by vonmoltke on Tuesday November 17, 2015 @10:51AM
(#10581831)
"Motivation" in the business sense of "can make sufficient return on investment", not the trivially reductionist sense of "I feel like making a new drug today". So regulatory costs affect the motivation.
Have you ever looked at the cost of getting a new manufacturer of a drug approved by the FDA? FDA approval requires a lot more than motivation; if you disagree, I invite you to start manufacturing the drugs yourself (or even contracting it out).